Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
While Novo Nordisks patent in the US is set to expire in 2032, its patents in other markets are set to expire much sooner
MeAgain keeps shots or pills, dose history, injection sites, food, protein, fiber, water, side effects, weight, progress photos, medication-level context, and Journey Cards on one timeline
Citations Citations and reference data
A retrospective analysis of more than 110,000 women between the ages of 45 and 80 found that those who took GLP-1 medications were about 30 percent less likely to develop breast cancer than those who did not take GLP-1 medications, according to research presented today at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting (Abstract 10506) by Elizabeth McDonald, MD, PhD, a professor of Radiology in the University of Pennsylvania Perelman School of Medicine and a practicing breast radiologist at Penns Abramson Cancer Center
The results indicated minimal off-target effect, consistent with previous reports of pDNA-mediated genome editing using this sgRNA 20
US$ 27.80
US$ 22.27
US$ 20.27
US$ 28.06
US$ 26.24
US$ 27.83
